Biotech ETFs Lose Some Shine

For the bulk of 2013, biotech exchange traded funds have been among the best at the industry level. Some of the bloom has come of that rose in recent weeks, but there may still be some opportunity left in these ETFs for investors willing to buy the pseudo dip. “Biotechnology investing, in our view,...